Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Hepatology

Understanding Your Budd-Chiari Syndrome Diagnosis

At a Glance

Budd-Chiari Syndrome (BCS) occurs when veins carrying blood out of the liver become blocked, causing liver congestion and swelling. With specialized care and modern treatments like blood thinners or the TIPS bypass procedure, most patients have an excellent long-term outlook and lead full lives.

Receiving a diagnosis of Budd-Chiari Syndrome (BCS) can feel overwhelming, especially if your local doctor or hospital hasn’t encountered it before. Because this condition is so rare, it is normal to feel like you are navigating uncharted territory. This page is designed to help you understand the basics of what is happening in your body and to reassure you that there is a clear path forward.

A Rare and Unique Diagnosis

Budd-Chiari Syndrome is an exceptionally rare condition, affecting approximately 1 in every 100,000 people globally [1][2]. Because it is so uncommon, many general practitioners or even local gastroenterologists may only see one case in their entire career.

If you feel like your medical team is learning along with you, you are not alone. While more patients are being identified and hospitalized for BCS today than in the past, it remains a “specialty” condition [3]. The most important first step is ensuring you are connected with a hepatologist (a liver specialist) at a center that has experience managing rare vascular liver diseases [4][5].

What is Budd-Chiari Syndrome?

In simple terms, Budd-Chiari Syndrome is a “plumbing” problem in the liver.

Your liver is a vital organ that filters your blood. Blood enters the liver through certain vessels and exits through the hepatic veins to return to your heart. BCS occurs when these exit veins become narrowed or blocked [6][7].

The Biological “Traffic Jam”

When the “exit doors” (the hepatic veins) are blocked, blood cannot leave the liver properly. This creates a biological traffic jam:

  • Congestion: Blood backs up into the liver, causing it to swell and become congested [8][6].
  • Pressure: This backup increases pressure within the liver’s blood vessels, a state called portal hypertension [9].
  • Fluid Leaks: The high pressure can cause fluid to leak out of the liver and into your abdominal cavity, a condition known as ascites [8][9]. Ascites often feels like a sudden tightening of your clothes, rapid weight gain, and sometimes shortness of breath as the fluid presses against your lungs.
  • Swollen Veins (Varices): Because blood cannot flow normally, it finds alternative routes, often causing the veins in your esophagus and stomach to swell. These are called varices and carry a serious risk of internal bleeding if they rupture [10].

The blockage is most often caused by a blood clot (also called thrombosis), though it can occasionally be caused by something outside the vein pressing on it [11][2].

Why Your Outlook is Hopeful

While the diagnosis is serious, the outlook for patients with BCS has improved dramatically over the last two decades. When managed at specialized centers using a “stepwise” approach, most patients lead full lives [4][5].

Modern treatment generally follows these stages:

  1. Medical Management: Using anticoagulants (blood thinners) to prevent new clots, diuretics (water pills) to manage fluid buildup, and sometimes beta-blockers or endoscopic procedures to manage the risk of bleeding from swollen veins (varices) [12][13].
  2. Opening the Veins: If medicine isn’t enough, doctors can often use minimally invasive procedures to clear the blockage or place a stent (a small mesh tube) to keep the vein open [14][15].
  3. Creating a Bypass (TIPS): A common and highly effective treatment is the TIPS procedure (Transjugular Intrahepatic Portosystemic Shunt). This creates a new path for blood to bypass the blockage and flow out of the liver safely [16][17].

Because of these advanced “bypass” techniques, the need for a liver transplant in BCS patients has become much less common [18][19]. At specialized centers, the long-term survival rates are excellent, and the focus is on maintaining your quality of life [16][20].

Return to the Budd-Chiari Syndrome Resource Guide.

Common questions in this guide

What causes Budd-Chiari Syndrome?
Budd-Chiari Syndrome is most commonly caused by a blood clot, also known as thrombosis, that blocks the hepatic veins. These veins serve as the main exit pathways for blood leaving the liver. Less commonly, it can be caused by something outside the vein pressing against it.
What kind of doctor treats Budd-Chiari Syndrome?
Because it is an exceptionally rare condition, you should be treated by a hepatologist, which is a doctor who specializes in liver diseases. It is highly recommended to seek care at a specialized medical center with a multidisciplinary team, including interventional radiologists.
What are the symptoms of fluid buildup in the liver?
Fluid buildup in the abdomen, known as ascites, often feels like a sudden tightening of your clothes or rapid weight gain. As the fluid accumulates, it can sometimes press against your lungs, leading to shortness of breath.
What is the TIPS procedure for liver blockages?
The TIPS procedure, or Transjugular Intrahepatic Portosystemic Shunt, is a highly effective, minimally invasive treatment for liver blockages. It creates a new pathway for blood to flow through the liver, bypassing the blockage and safely relieving dangerous pressure.
Will I need a liver transplant for Budd-Chiari Syndrome?
Thanks to modern treatments and minimally invasive bypass procedures like TIPS, the need for a liver transplant is much less common today. When managed at specialized centers using a step-by-step approach, most patients are able to lead full lives without a transplant.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many patients with Budd-Chiari Syndrome do you or this facility treat each year?
  2. 2.Do you work with a multidisciplinary team, including interventional radiologists and hepatologists, who specialize in vascular liver diseases?
  3. 3.Based on my imaging, is my blockage caused by a blood clot, a web, or something else?
  4. 4.Am I a candidate for a stepwise treatment approach starting with anticoagulation, or do I need an intervention like TIPS right away?
  5. 5.What is the long-term plan for monitoring my liver health and prevent new clots from forming?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    A Rare Case of Budd-Chiari Syndrome in a Young Female.

    Chacko J, Haward R, Shah NA, et al.

    Clinical case reports 2025; (13(5)):e70478 doi:10.1002/ccr3.70478.

    PMID: 40321226
  2. 2

    Review article: a multidisciplinary approach to the diagnosis and management of Budd-Chiari syndrome.

    Khan F, Armstrong MJ, Mehrzad H, et al.

    Alimentary pharmacology & therapeutics 2019; (49(7)):840-863 doi:10.1111/apt.15149.

    PMID: 30828850
  3. 3

    A Nationwide Analysis of Budd-Chiari Syndrome in the United States.

    Alukal JJ, Zhang T, Thuluvath PJ

    Journal of clinical and experimental hepatology 2021; (11(2)):181-187 doi:10.1016/j.jceh.2020.08.005.

    PMID: 33746442
  4. 4

    Budd-Chiari Syndrome.

    Grus T, Lambert L, Grusová G, et al.

    Prague medical report 2017; (118(2-3)):69-80 doi:10.14712/23362936.2017.6.

    PMID: 28922103
  5. 5

    Primary Budd-Chiari syndrome due to lupus anticoagulant positive antiphospholipid syndrome.

    J U S, Premkumar S, Sivaprakasam E

    BMJ case reports 2025; (18(10)) doi:10.1136/bcr-2025-267045.

    PMID: 41151826
  6. 6

    Living donor liver transplantation for adult Budd Chiari syndrome - Resection without replacement of retrohepatic IVC: A case report.

    Sabra TA, Okajima H, Tajima T, et al.

    International journal of surgery case reports 2018; (42()):50-54 doi:10.1016/j.ijscr.2017.11.050.

    PMID: 29216531
  7. 7

    Early radiological intervention and haematology screening is associated with excellent outcomes in Budd-Chiari syndrome.

    Mo A, Testro A, French J, et al.

    Internal medicine journal 2017; (47(12)):1361-1367 doi:10.1111/imj.13544.

    PMID: 28675622
  8. 8

    Common features of Budd Chiari syndrome in Sudanese population: a computed tomography-based review and descriptive analysis.

    Ali Bakry AH, Bashir A, Almuqbil N, et al.

    Frontiers in medicine 2025; (12()):1552366 doi:10.3389/fmed.2025.1552366.

    PMID: 41221516
  9. 9

    Budd-Chiari Syndrome following COVID-19 infection: a case report.

    Sawaqed SS, Urabi HM, Al-Thnaibat MH, et al.

    Annals of medicine and surgery (2012) 2023; (85(9)):4570-4574 doi:10.1097/MS9.0000000000001078.

    PMID: 37663747
  10. 10

    Management of splanchnic vein thrombosis.

    Elkrief L, Payancé A, Plessier A, et al.

    JHEP reports : innovation in hepatology 2023; (5(4)):100667 doi:10.1016/j.jhepr.2022.100667.

    PMID: 36941824
  11. 11

    Imaging findings of Budd-Chiari syndrome caused by intravenous leiomyomatosis: a case report.

    Wang Y, Dong Y, Tian X, et al.

    Frontiers in medicine 2024; (11()):1422652 doi:10.3389/fmed.2024.1422652.

    PMID: 39193014
  12. 12

    Recent outcomes of liver transplantation for Budd-Chiari syndrome: A study of the European Liver Transplant Registry (ELTR) and affiliated centers.

    Dongelmans E, Erler N, Adam R, et al.

    Hepatology (Baltimore, Md.) 2024; (80(1)):136-151 doi:10.1097/HEP.0000000000000778.

    PMID: 38358658
  13. 13

    Budd-Chiari Syndrome and Pregnancy-A Review.

    Giri S, Malakar S, Sahoo S, et al.

    Journal of clinical and experimental hepatology 2026; (16(1)):103176 doi:10.1016/j.jceh.2025.103176.

    PMID: 41019147
  14. 14

    Early Endovascular Intervention in Combination with Medical Therapy versus Medical Therapy Alone in the Initial Management of Patients with Primary Budd-Chiari Syndrome: A Randomized Controlled Trial.

    Biswas S, Swaroop S, Mehta S, et al.

    Journal of vascular and interventional radiology : JVIR 2026; (37(3)):107967 doi:10.1016/j.jvir.2025.107967.

    PMID: 41421590
  15. 15

    Acute-on-Chronic Liver Failure in Budd-Chiari Syndrome: Profile and Predictors of Outcome.

    Shalimar , Sharma S, Gamanagatti SR, et al.

    Digestive diseases and sciences 2020; (65(9)):2719-2729 doi:10.1007/s10620-019-06005-7.

    PMID: 31897895
  16. 16

    Long-term outcomes of transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome: A multicenter study.

    Swaroop S, Janeela AM, Valsan A, et al.

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2025; (57(10)):1958-1964 doi:10.1016/j.dld.2025.06.026.

    PMID: 40716963
  17. 17

    TEN-YEAR OUTCOMES OF TIPS FOR BUDD-CHIARI SYNDROME: SYSTEMATIC REVIEW AND META-ANALYSIS.

    Moreno MOA, Paz CLDSL, Dezan MGF, et al.

    Arquivos de gastroenterologia 2024; (61()):e23171 doi:10.1590/S0004-2803.24612023-171.

    PMID: 38896573
  18. 18

    Long Term Survival of Patients Undergoing TIPS in Budd-Chiari Syndrome.

    Sonavane AD, Amarapurkar DN, Rathod KR, Punamiya SJ

    Journal of clinical and experimental hepatology 2019; (9(1)):56-61 doi:10.1016/j.jceh.2018.02.008.

    PMID: 30765940
  19. 19

    Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension: Review and Update of the Literature.

    Hung ML, Lee EW

    Clinics in liver disease 2019; (23(4)):737-754 doi:10.1016/j.cld.2019.07.004.

    PMID: 31563220
  20. 20

    Comparison of direct intrahepatic portosystemic shunt and other major radiological interventions in patients with Budd-Chiari syndrome.

    Malakar S, Shah N, Hoda US, et al.

    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 2025; (44(5)):708-718 doi:10.1007/s12664-024-01733-9.

    PMID: 40053055

This page provides an educational overview of Budd-Chiari Syndrome for informational purposes only. It does not replace professional medical advice, and you should always consult a hepatologist or liver specialist regarding your specific care plan.

Get notified when new evidence is published on Budd-Chiari syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.